![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GAN |
Gene summary for GAN |
![]() |
Gene information | Species | Human | Gene symbol | GAN | Gene ID | 8139 |
Gene name | gigaxonin | |
Gene Alias | GAN1 | |
Cytomap | 16q23.2 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | A0A0S2Z4W2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8139 | GAN | CCI_1 | Human | Cervix | CC | 4.32e-13 | 7.07e-01 | 0.528 |
8139 | GAN | CCI_2 | Human | Cervix | CC | 3.18e-07 | 7.64e-01 | 0.5249 |
8139 | GAN | CCI_3 | Human | Cervix | CC | 2.75e-12 | 7.43e-01 | 0.516 |
8139 | GAN | Tumor | Human | Cervix | CC | 5.14e-07 | 2.04e-01 | 0.1241 |
8139 | GAN | LZE22T | Human | Esophagus | ESCC | 1.23e-02 | 1.30e-01 | 0.068 |
8139 | GAN | P2T-E | Human | Esophagus | ESCC | 8.79e-06 | -5.63e-02 | 0.1177 |
8139 | GAN | P4T-E | Human | Esophagus | ESCC | 2.50e-06 | -4.93e-02 | 0.1323 |
8139 | GAN | P5T-E | Human | Esophagus | ESCC | 2.60e-11 | -3.88e-02 | 0.1327 |
8139 | GAN | P8T-E | Human | Esophagus | ESCC | 2.19e-24 | 7.83e-02 | 0.0889 |
8139 | GAN | P9T-E | Human | Esophagus | ESCC | 4.51e-08 | 4.91e-02 | 0.1131 |
8139 | GAN | P10T-E | Human | Esophagus | ESCC | 1.45e-12 | 1.12e-01 | 0.116 |
8139 | GAN | P11T-E | Human | Esophagus | ESCC | 2.71e-02 | 1.97e-01 | 0.1426 |
8139 | GAN | P12T-E | Human | Esophagus | ESCC | 4.29e-15 | -1.83e-02 | 0.1122 |
8139 | GAN | P15T-E | Human | Esophagus | ESCC | 1.37e-07 | 1.32e-01 | 0.1149 |
8139 | GAN | P16T-E | Human | Esophagus | ESCC | 8.83e-07 | -8.29e-02 | 0.1153 |
8139 | GAN | P20T-E | Human | Esophagus | ESCC | 2.42e-10 | 1.12e-01 | 0.1124 |
8139 | GAN | P21T-E | Human | Esophagus | ESCC | 1.39e-05 | 3.31e-02 | 0.1617 |
8139 | GAN | P22T-E | Human | Esophagus | ESCC | 7.19e-12 | 8.98e-02 | 0.1236 |
8139 | GAN | P23T-E | Human | Esophagus | ESCC | 6.87e-11 | 6.04e-01 | 0.108 |
8139 | GAN | P24T-E | Human | Esophagus | ESCC | 1.28e-11 | -3.58e-02 | 0.1287 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00091002 | Esophagus | ESCC | glycoprotein metabolic process | 226/8552 | 387/18723 | 2.64e-07 | 3.94e-06 | 226 |
GO:00442626 | Esophagus | ESCC | cellular carbohydrate metabolic process | 160/8552 | 283/18723 | 1.43e-04 | 9.66e-04 | 160 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
GO:00091001 | Oral cavity | OSCC | glycoprotein metabolic process | 185/7305 | 387/18723 | 2.37e-04 | 1.54e-03 | 185 |
GO:00442625 | Oral cavity | OSCC | cellular carbohydrate metabolic process | 130/7305 | 283/18723 | 9.98e-03 | 3.49e-02 | 130 |
GO:00091003 | Thyroid | PTC | glycoprotein metabolic process | 147/5968 | 387/18723 | 5.87e-03 | 2.64e-02 | 147 |
GO:000910011 | Thyroid | ATC | glycoprotein metabolic process | 153/6293 | 387/18723 | 7.90e-03 | 3.06e-02 | 153 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GAN | insertion | Nonsense_Mutation | novel | c.1763_1764insTTAGA | p.Leu589Ter | p.L589* | Q9H2C0 | protein_coding | TCGA-A5-A0GW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
GAN | insertion | Nonsense_Mutation | novel | c.1765_1766insGAGGTTATGCAGTTTGGCAATACCACAGAAGTCA | p.Leu589Ter | p.L589* | Q9H2C0 | protein_coding | TCGA-A5-A0GW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
GAN | deletion | In_Frame_Del | c.838_840delNNN | p.Gly280del | p.G280del | Q9H2C0 | protein_coding | TCGA-AP-A05N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
GAN | insertion | In_Frame_Ins | novel | c.1716_1717insACA | p.Ala572_Leu573insThr | p.A572_L573insT | Q9H2C0 | protein_coding | TCGA-D1-A0ZU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | ||
GAN | insertion | In_Frame_Ins | novel | c.1718_1719insTAACTGGAGGAACTC | p.Leu573delinsPheAsnTrpArgAsnSer | p.L573delinsFNWRNS | Q9H2C0 | protein_coding | TCGA-D1-A0ZU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | ||
GAN | SNV | Missense_Mutation | novel | c.182N>G | p.Tyr61Cys | p.Y61C | Q9H2C0 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-K7-AAU7-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Chemotherapy | gemcitabine | PD |
GAN | SNV | Missense_Mutation | rs766484755 | c.565N>T | p.Val189Phe | p.V189F | Q9H2C0 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-05-4249-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
GAN | SNV | Missense_Mutation | c.860N>G | p.Lys287Arg | p.K287R | Q9H2C0 | protein_coding | tolerated(0.15) | benign(0.028) | TCGA-44-3918-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | |
GAN | SNV | Missense_Mutation | rs766484755 | c.565G>T | p.Val189Phe | p.V189F | Q9H2C0 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-53-7626-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unspecific | Cisplatin | PD |
GAN | SNV | Missense_Mutation | novel | c.994G>T | p.Gly332Trp | p.G332W | Q9H2C0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-53-7626-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unspecific | Cisplatin | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |